ROYSTON IVOR (CEO & President) exercised options at VIRACTA THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/28/2023ACC: 0001209191-23-056840
DirectorOfficer· CEO & President
Since Feb 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
25.22K acquired · 25.22K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.22K
Price / share
—
Trade value
—
% of position
3.5%
11/25/2023
713.65K→738.87K
Total
Net shares
+25.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2023 | M · Option Exercise | +25.22K | — | — | 3.5% | 713.65K | 738.87K |
| Total | +25.22K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
25.22K shares
Shares
−25.22K
Strike price
Held after
151.31K
Exercisable
—
11/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock25.22K shares | 11/25/2023 | M · Option Exercise | −25.22K | — | 151.31K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned18.60K
Total
18.60K indirect18.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.60K | Indirect |
| Total | 18.60K | 18.60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported